**Core Concept:** Erythropoietin is a glycoprotein hormone produced primarily in the kidneys in response to hypoxia, which stimulates the production of red blood cells in the bone marrow. It acts on the erythroid progenitor cells, promoting their proliferation, differentiation, and survival.

**Why the Correct Answer is Right:** Erythropoietin is primarily produced in the kidneys in response to hypoxia (low oxygen levels) to increase red blood cell production. By doing so, it helps maintain adequate oxygen delivery to tissues.

**Why Each Wrong Option is Incorrect:**

A. This statement is true: Erythropoietin stimulates red blood cell production in the bone marrow. However, Option A does not address the primary production site (kidneys), so it is not entirely incorrect.

B. This statement is true: Erythropoietin acts on erythroid progenitor cells. However, Option B does not address the primary production site (kidneys), making it not entirely correct.

C. This statement is true: Hypoxia is a stimulus for erythropoietin production. Although Option C is partially correct, it does not address the primary production site (kidneys).

D. This statement is false: Erythropoietin is not primarily produced in the liver. While this option addresses the correct tissue (liver), it is incorrect because erythropoietin is produced in the kidneys, not liver.

**Clinical Pearl:** Understanding the correct production site and primary function of erythropoietin is essential in interpreting clinical scenarios involving anemia, renal disease, or conditions affecting erythropoietin production or action (e.g., hypoxia, polycythemia, and erythropoietin inhibitors).

**Correct Answer:** D. Erythropoietin is not primarily produced in the liver (false). The correct statement should be: Erythropoietin is primarily produced in the kidneys in response to hypoxia.